Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation.
There is increasing evidence that D-hormones (active vitamin D metabolites) are effective agents in preventing posttransplantation bone loss of various organs. This effect may relate to several mechanisms including reversal of secondary hyperparathyroidism from cyclosporine, reversal of corticosteroid effects on bone, or immunomodulatory effects with corticosteroid sparing. Further clinical trials are necessary to establish their comparative efficacy to other agents, but D-hormones should be considered as prophylactic therapy in patients undergoing organ transplantation.
Sambrook
P
P
Department of Rheumatology, University of Sydney, Royal North Shore Hospital, Sydney, 2065, Australia.
D002117:Calcitriol / Q000494:pharmacology*; D004164:Diphosphonates; D006801:Humans; D006887:Hydroxycholecalciferols / Q000494:pharmacology*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016377:Organ Transplantation / Q000009:adverse effects*; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control*
D004164:Diphosphonates; D006887:Hydroxycholecalciferols; D007166:Immunosuppressive Agents; D002117:Calcitriol; C008088:alfacalcidol